Escalating Beyond Corticosteroids in Ocular and Lower-Burden MG

04 Nov 2026 0 comments

The decision to escalate MG therapy is driven by more than numerical disease severity. Persistent functional impairment may justify earlier targeted treatment even when symptoms appear clinically modest.

Source: NeurologyLive Published 04 Nov 2026 Imported 04 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment